Williamson Robert F III
SEC insider (Form 3/4/5 filer). CIK 0001397331. Director at Perspective Therapeutics, Inc. (CATX). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.
Companies Williamson Robert F III has filed insider reports for
- Perspective Therapeutics, Inc. (CATX): Director
Williamson Robert F III
CIK: 0001397331
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Perspective Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 2, 2026CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
50K shares- - Nov 12, 2025CATX
Perspective Therapeutics, Inc.
PurchaseIndirect9.5K shares at avg. $2.10$20K - Mar 31, 2025CATX
Perspective Therapeutics, Inc.
PurchaseDirect38.1K shares at avg. $2.14$82K - Mar 28, 2025CATX
Perspective Therapeutics, Inc.
PurchaseDirect22.2K shares at avg. $2.27$50K - Mar 3, 2025CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
50K shares- - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect2.6K shares at avg. $3.67$10K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect3.6K shares at avg. $3.62$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 50,000 | - | - | Direct |
| Nov 12, 2025 | CATX Perspective Therapeutics, Inc. | Purchase | 9,498 | $2.10 | $19,946 | Indirect |
| Mar 31, 2025 | CATX Perspective Therapeutics, Inc. | Purchase | 38,145 | $2.14 | $81,775 | Direct |
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | Purchase | 22,192 | $2.27 | $50,376 | Direct |
| Mar 3, 2025 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 50,000 | - | - | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 2,619 | $3.67 | $9,612 | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 3,647 | $3.62 | $13,202 | Direct |
1-7 of 7 transactions